Search results
Order by most recent / most popular / relevance
Results: 1-10 of 61
Genetic technologies settles infringement suit over non-DNA coding technology
- Shook Hardy & Bacon LLP
- -
- USA
- -
- May 2 2013
Genetic Technologies Ltd. (GTG) has reportedly settled a patent infringement lawsuit filed in late 2012 against PreventionGenetics. While the terms
Indian Supreme Court rules Novartis cancer drug change not patentable
- Shook Hardy & Bacon LLP
- -
- India
- -
- April 4 2013
The Supreme Court of India has rejected the patent application filed by Novartis AG for a beta crystalline form of its cancer drug Gleevec, also
SCOTUS hears arguments on patentability of human genes
- Shook Hardy & Bacon LLP
- -
- USA
- -
- April 18 2013
The U.S. Supreme Court (SCOTUS) heard arguments on Monday specifically addressing whether "human genes are patentable." Ass'n for Molecular Pathology
Drug companies and policymakers watch patent dispute before India’s high court
- Shook Hardy & Bacon LLP
- -
- India
- -
- March 15 2012
According to a news source, the India Supreme Court will hear final arguments in March 2012 on whether the manufacturer of a drug that could not be patented in India because it was created before 1995 during a moratorium on the grant of patents to Western companies, may obtain a patent in that country for a newer form of the drug
Eleventh Circuit turns aside FTC challenge to pay-for-delay deal
- Shook Hardy & Bacon LLP
- -
- USA
- -
- May 3 2012
The Eleventh Circuit Court of Appeals has dismissed an antitrust action filed by the Federal Trade Commission (FTC) against a name-brand prescription drug manufacturer (the patent holder) and generic drug companies that entered into pay-for-delay agreements to settle patent infringement claims filed against the generic drug companies
Study shows rise in biotech patent litigation
- Shook Hardy & Bacon LLP
- -
- USA
- -
- September 20 2012
PricewaterhouseCoopers LLP has released its “2012 Patent Litigation Study,” which shows that the 4,105 patent lawsuits filed in 2011 marked a high point and a 22-percent increase from the previous year
Federal Circuit’s patent infringement ruling conflicts with USPTO re-examination on validity
- Shook Hardy & Bacon LLP
- -
- USA
- -
- November 1 2012
The Federal Circuit Court of Appeals has denied a request for an en banc rehearing by a medical-device patent holder which argued that the U.S. Patent and Trademark Office’s (USPTO’s) Board of Patent Appeals had effectively nullified a previous Federal Circuit decision on the validity of its patent
Moody’s claims “the worst is over” for pharmaceutical companies facing patent cliff
- Shook Hardy & Bacon LLP
- -
- USA
- -
- October 3 2012
Moody’s Investor Services has reportedly revised its outlook for the global pharmaceutical industry and upgraded it to stable, apparently anticipating that earnings will rebound in 2013 with the slowdown in patent expirations, characterized by many industry observers as the “patent cliff.”
Federal Ccircuit panel returns to Gore-Tex graft dispute, clarifies willfulness standard for enhanced damages
- Shook Hardy & Bacon LLP
- -
- USA
- -
- June 21 2012
The Federal Circuit Court of Appeals has vacated parts of its February 2012 decision in a long-running patent dispute over a prosthetic vascular graft and remanded the matter for the district court to address the objective prong of the willfulness standard and reconsider its denial of W.L. Gore’s motion for judgment as a matter of law of no willful infringement. Bard Peripheral Vascular, Inc. v. W.L. Gore & Assoc., Inc., No. 2010-1510 (Fed. Cir., decided June 14, 2012
News Bytes - April 18, 2013
- Shook Hardy & Bacon LLP
- -
- USA
- -
- April 18 2013
The U.S. Department of Commerce announces the winners of the U.S. Patent and Trademark Office's Patents for Humanity pilot program. The awards
Current Search
- Workarea - Patents
- Workarea - Healthcare
- Author - Chris A. Johnson
- Firm Name - Shook Hardy & Bacon LLP